Cargando…

Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism

BACKGROUND: Orbitofrontal cortex alterations have been suggested to underlie the impaired mood regulation in depression. MAOA-uVNTR (monoamine oxidase A-upstream variable number of tandem repeats) polymorphism has been reported to be associated with major depressive disorder by various studies. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Won, Eunsoo, Choi, Sunyoung, Kang, June, Lee, Min-Soo, Ham, Byung-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062832/
https://www.ncbi.nlm.nih.gov/pubmed/27752275
http://dx.doi.org/10.1186/s12991-016-0116-0
_version_ 1782459855057977344
author Won, Eunsoo
Choi, Sunyoung
Kang, June
Lee, Min-Soo
Ham, Byung-Joo
author_facet Won, Eunsoo
Choi, Sunyoung
Kang, June
Lee, Min-Soo
Ham, Byung-Joo
author_sort Won, Eunsoo
collection PubMed
description BACKGROUND: Orbitofrontal cortex alterations have been suggested to underlie the impaired mood regulation in depression. MAOA-uVNTR (monoamine oxidase A-upstream variable number of tandem repeats) polymorphism has been reported to be associated with major depressive disorder by various studies. The influence of MAOA-uVNTR genotype on function and structure of the orbitofrontal cortex has previously been reported. In this study, we investigated the difference in orbitofrontal cortex thickness between medication-naïve female patients with major depressive disorder and healthy controls, and the influence of MAOA-uVNTR genotype on orbitofrontal cortex thickness in depression. METHODS: Thirty-one patients with major depressive disorder and 43 healthy controls were included. All participants were subjected to T1-weighted structural magnetic resonance imaging and genotyped for MAOA-uVNTR polymorphism. An automated procedure of FreeSurfer was used to analyze difference in orbitofrontal cortex thickness. RESULTS: Patients showed a significantly thinner left orbitofrontal cortex (F ((1,71)) = 7.941, p = 0.006) and right orbitofrontal cortex (F ((1,71)) = 17.447, p < 0.001). For the orbitofrontal cortex sub-region analysis, patients showed a significantly thinner left medial orbitofrontal cortex (F ((1,71)) = 8.117, p = 0.006), right medial orbitofrontal cortex (F ((1,71)) = 21.795, p < 0.001) and right lateral orbitofrontal cortex (F ((1,71)) = 9.932, p = 0.002) compared to healthy controls. No significant interaction of diagnosis and MAOA-uVNTR genotype on orbitofrontal cortex thickness was revealed. CONCLUSIONS: Our results suggest that structural alterations of the orbitofrontal cortex may be associated with the pathophysiology of major depressive disorder. Future studies with larger sample sizes are needed to detect a possible association between MAOA-uVNTR genotype and orbitofrontal cortex thickness in depression.
format Online
Article
Text
id pubmed-5062832
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50628322016-10-17 Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism Won, Eunsoo Choi, Sunyoung Kang, June Lee, Min-Soo Ham, Byung-Joo Ann Gen Psychiatry Primary Research BACKGROUND: Orbitofrontal cortex alterations have been suggested to underlie the impaired mood regulation in depression. MAOA-uVNTR (monoamine oxidase A-upstream variable number of tandem repeats) polymorphism has been reported to be associated with major depressive disorder by various studies. The influence of MAOA-uVNTR genotype on function and structure of the orbitofrontal cortex has previously been reported. In this study, we investigated the difference in orbitofrontal cortex thickness between medication-naïve female patients with major depressive disorder and healthy controls, and the influence of MAOA-uVNTR genotype on orbitofrontal cortex thickness in depression. METHODS: Thirty-one patients with major depressive disorder and 43 healthy controls were included. All participants were subjected to T1-weighted structural magnetic resonance imaging and genotyped for MAOA-uVNTR polymorphism. An automated procedure of FreeSurfer was used to analyze difference in orbitofrontal cortex thickness. RESULTS: Patients showed a significantly thinner left orbitofrontal cortex (F ((1,71)) = 7.941, p = 0.006) and right orbitofrontal cortex (F ((1,71)) = 17.447, p < 0.001). For the orbitofrontal cortex sub-region analysis, patients showed a significantly thinner left medial orbitofrontal cortex (F ((1,71)) = 8.117, p = 0.006), right medial orbitofrontal cortex (F ((1,71)) = 21.795, p < 0.001) and right lateral orbitofrontal cortex (F ((1,71)) = 9.932, p = 0.002) compared to healthy controls. No significant interaction of diagnosis and MAOA-uVNTR genotype on orbitofrontal cortex thickness was revealed. CONCLUSIONS: Our results suggest that structural alterations of the orbitofrontal cortex may be associated with the pathophysiology of major depressive disorder. Future studies with larger sample sizes are needed to detect a possible association between MAOA-uVNTR genotype and orbitofrontal cortex thickness in depression. BioMed Central 2016-10-12 /pmc/articles/PMC5062832/ /pubmed/27752275 http://dx.doi.org/10.1186/s12991-016-0116-0 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Primary Research
Won, Eunsoo
Choi, Sunyoung
Kang, June
Lee, Min-Soo
Ham, Byung-Joo
Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism
title Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism
title_full Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism
title_fullStr Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism
title_full_unstemmed Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism
title_short Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism
title_sort regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with maoa-uvntr polymorphism
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062832/
https://www.ncbi.nlm.nih.gov/pubmed/27752275
http://dx.doi.org/10.1186/s12991-016-0116-0
work_keys_str_mv AT woneunsoo regionalcorticalthinningoftheorbitofrontalcortexinmedicationnaivefemalepatientswithmajordepressivedisorderisnotassociatedwithmaoauvntrpolymorphism
AT choisunyoung regionalcorticalthinningoftheorbitofrontalcortexinmedicationnaivefemalepatientswithmajordepressivedisorderisnotassociatedwithmaoauvntrpolymorphism
AT kangjune regionalcorticalthinningoftheorbitofrontalcortexinmedicationnaivefemalepatientswithmajordepressivedisorderisnotassociatedwithmaoauvntrpolymorphism
AT leeminsoo regionalcorticalthinningoftheorbitofrontalcortexinmedicationnaivefemalepatientswithmajordepressivedisorderisnotassociatedwithmaoauvntrpolymorphism
AT hambyungjoo regionalcorticalthinningoftheorbitofrontalcortexinmedicationnaivefemalepatientswithmajordepressivedisorderisnotassociatedwithmaoauvntrpolymorphism